Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr., 12 January 2026

Sec. Nutritional Epidemiology

Volume 12 - 2025 | https://doi.org/10.3389/fnut.2025.1738146

Adherence to Life’s Essential 8 is associated with lower risk of hyperuricemia among adults in Beijing, China

Rui DengRui DengJiali DuanJiali DuanBo YuBo YuYan ZhangYan ZhangYihong YaoYihong YaoRui MaRui MaYimei Sha
Yimei Sha*
  • Institute of Nutrition and Food Hygiene, Beijing Center for Disease Prevention and Control, Beijing, China

Background: Hyperuricemia is linked to various cardiovascular diseases, yet evidence on the association of Life’s Essential 8, a newly updated metric for cardiovascular health, with hyperuricemia in the general Chinese population remains scarce.

Methods: Data were obtained from 1,519 adults in Beijing as part of the Chinese Nutrition and Health Surveillance 2022. Logistic regression and restricted cubic spline models were used to assess the associations of Life’s Essential 8 score and its subscales with the risk of hyperuricemia. Stratified analyses by key demographic variables were also performed.

Results: The prevalence of hyperuricemia was 13.76%. For every 10-unit increase in Life’s Essential 8 score and its subscale of health factor scores, the risk of hyperuricemia decreased by 24% (OR = 0.76, 95% CI = 0.66 ~ 0.87) and 23% (OR = 0.77, 95% CI = 0.70 ~ 0.84), respectively. Participants with high Life’s Essential 8 scores had a lower risk of hyperuricemia compared with those with low Life’s Essential 8 scores (OR = 0.32, 95% CI = 0.14 ~ 0.74), and similar results were found for those with high health factor scores (OR = 0.29, 95% CI = 0.17 ~ 0.49). These associations were more pronounced among participants who had high educational levels and middle-class annual household incomes.

Conclusion: Our study revealed a negative association of the Life’s Essential 8 score with the risk of hyperuricemia in the general population of Beijing, China, which was also observed for its health factor subscale, highlighting the promise of adherence to the Life’s Essential 8 to maintain cardiovascular health and thereby reduce the disease burden of hyperuricemia.

1 Introduction

Hyperuricemia is a condition characterized primarily by elevated blood uric acid levels and is typically diagnosed when uric acid levels exceed 416.5 μmol/L in men and 357.0 μmol/L in women (1). Data from the National Health and Nutrition Examination Survey in the United States revealed that the prevalence of hyperuricemia remained relatively stable at around 20% from 2007 to 2016 (2). However, in Chinese adults, a study reported that the overall prevalence of hyperuricemia significantly increased from 11.1% (10.3%~11.8%) in 2015~2016 to 14.0% (13.1%~14.8%) in 2018~2019 (3). Given that high levels of blood uric acid are the main cause of gout, 36% of patients with hyperuricemia ultimately developed gout (4). In addition to gout, hyperuricemia is also associated with several diseases, such as metabolic syndrome (5), hypertension (6), diabetes (7) and kidney diseases (8).

Evidence has shown that adherence to healthy lifestyles can reduce serum uric acid levels by 70 ~ 90 μmol/L and the risk of hyperuricemia incidence by 41% (9, 10). However, the definitions of lifestyle components varied widely across these studies. Furthermore, hyperuricemia has been established as a risk factor for cardiovascular diseases (8). For instance, evidence from meta-analyses showed that hyperuricemia was associated with 22 and 33% greater risks of stroke incidence and mortality, respectively (11), and 41% increases in the risk of incident hypertension (12). These findings underscored the importance of maintaining cardiovascular health in its prevention. In 2020, to improve the cardiovascular health (CVH) of populations, the American Heart Association formulated an accessible and actionable definition of lifestyle for individuals, researchers and practitioners, called Life’s Simple 7 (13), which includes seven components: dietary quality, physical activity, exposure to cigarette smoking, body mass index status, and blood pressure, blood glucose and blood lipid levels. After 12 years of practice and application of Life’s Simple 7, the American Heart Association updated the definition and approach for CVH measurement in 2022 (14), named Life’s Essential 8 (14). This update added sleep health as a new metric and used a more comprehensive scoring algorithm to capture interindividual differences more sensitively than Life’s Simple 7.

Therefore, exploring whether higher Life’s Essential 8 scores (LES) contribute to a lower risk of hyperuricemia is necessary and valuable. Nevertheless, limited studies have detected this association, and existing research evidence predominantly derived from adults in United States (1518). These studies collectively reported a significant negative relationship between LES and hyperuricemia, indicating that participants with high LES had 50 to 80% lower odds of hyperuricemia. For Chinese population, only two existing studies examined this association and showed similar results, but were conducted among elderly or multiethnic groups (19, 20), with little evidence regarding Chinese adults in the general population.

In this study, we aimed to identify the newly updated LES and explore its association with the risk of hyperuricemia in the general population in Beijing, China, with a focus on efforts for hyperuricemia prevention and related strategy formulation.

2 Materials and methods

2.1 Data source

Data were obtained from the Beijing subset of the Chinese Nutrition and Health Surveillance (CNHS) in 2022. The CNHS is a nationally representative cross-sectional study in mainland China. Using a multistage, stratified, and random sampling method, residents from 31 provinces were surveyed. Detailed information on the study protocol, sampling strategy, methodology, and quality assurance procedures can be found elsewhere (21). We utilized data from Beijing, which included a total of 3,952 participants, as the study population. Eligible participants were adults aged above 18 years who had plausible energy intake, complete data on physical measurements, laboratory tests, socioeconomic and lifestyle information, and an absence of any previously diagnosed serious diseases. Finally, 1,519 participants were included in this study. The process of sample selection is shown in Figure 1. The CNHS survey was approved by the Ethical Committee of the Chinese Center for Disease Control and Prevention (No: 201614). All the participants signed informed consent before the survey.

Figure 1
Flowchart showing participant exclusion from a study in Beijing, CNHS 2022. Initially, 3,952 participants were included. Exclusions were based on these criteria: children, adolescents, pregnant or nursing mothers (1,317); incomplete tests (396); missing information (431); implausible energy intake (199); and previous diagnoses of ASCVD, stroke, cancer, CKD, or gout (90). Final eligible participants total 1,519.

Figure 1. Flow chart of participant selection. Abbreviations: CNHS, China Nutrition and Health Surveillance; ASCVD, atherosclerosis cardiovascular disease; CKD, chronic kidney disease. aImplausible daily energy intake was defined as <500 or >5,000 kcal/d.

2.2 Indicators

2.2.1 The Life’s Essential 8 score (LES)

The LES was calculated in accordance with the definitions and algorithms provided by the American Heart Association in 2022 (14). There are eight indicators in the LES, each with a score range of 0~100 points, comprising diet, physical activity, sleep, nicotine exposure, body mass index (BMI), blood glucose, blood pressure and non-HDL-C. Dietary intake was assessed via a food frequency questionnaire, and diet quality was evaluated via the Dietary Approaches to Stop Hypertension (DASH) diet score. The DASH diet score is the sum of eight component scores, each corresponding to a specific food domain: fruits, vegetables, nuts and legumes; low-fat dairy products; whole grains; sodium; sweetened beverages; and red and processed meats (22). For the first five components (fruits to whole grains), participants in the highest quintile received 5 points, and those in the lowest quintile received 1 point. For the remaining components (sodium to red and processed meats), this scoring was reversed (highest quintile = 1 point, lowest quintile = 5 points). The total score ranged from 8 to 40, with higher scores indicating greater adherence to the DASH diet. Finally, on the basis of the 90th, 75th, 50th, and 25th percentiles of the DASH score (22), participants were assigned scores of 100, 80, 50, 25, and 0 for the LES, respectively. Physical activity was defined as self-reported minutes of moderate or vigorous physical activity per week. According to the scoring criteria of LES, participants with more than 150 min of moderate or vigorous physical activity per week received 100 points, with a deduction of 10 points for each subsequent 30-min decrease (23). Sleep health was defined as self-reported average hours of sleep with 7~9 h earning the maximum score. Nicotine exposure included self-reported use of cigarettes and second-hand smoke exposure, with never smoking considered ideal. BMI was calculated as body weight (kilogram, kg) divided by height squared (meter, m). Blood glucose was defined as levels of plasma hemoglobinA1c, with a self-reported history of diabetes from the questionnaire used as a supplementary criterion. Blood pressure was measured via auscultatory method, with systolic and diastolic pressures defined by Korotkoff sounds. Three consecutive readings were taken for each participant, and the mean of these measurements was used for analyses. Non-HDL-C was defined as total cholesterol minus high-density lipoprotein cholesterol. Specific scoring details for calculating LES for each metric could be found elsewhere (14).

The overall LES was calculated as the unweighted average of all eight metric scores. LESs were classified as follows: high (80~100 points), indicating high CVH; moderate (50~79 points), indicating moderate CVH; and low (0~49 points), indicating low CVH. With the same calculation method and cutoff points, the subscales of health behaviors scores (HBS) was defined as the average of diet, physical activity, sleep and nicotine exposure, and health factor scores (HFS) was defined as that of BMI, blood glucose, blood pressure and non-HDL-C.

2.2.2 Diagnosis of hyperuricemia

Fasting venous blood samples were collected during physical examinations, and serum uric acid levels were measured via the enzymatic kinetic method on a Randox/Hitachi 7600 automated analyzer. Hyperuricemia was diagnosed as a serum uric acid level >420 μmol/L for males and >360 μmol/L for females.

2.3 Covariates

The covariates in this study consisted of demographic information (age, sex, living area, ethnicity, education, income, and marital status) assessed through standardized questionnaires, and the estimated glomerular filtration rate (eGFR) derived from the CKD-EPI creatinine equation using serum creatinine, age, sex, and race. Age was categorized into three groups (18~44 years, 45~59 years and above 60 years). Educational level was classified as junior high school or below, high school, or college or above. Annual household income per capita was categorized into three groups using thresholds of 20,000 Chinese Yuan (CNY) and 50,000 CNY based on the definition in previous study (24), as well as sample balance and the economic conditions in the capital region.

2.4 Statistical analysis

Categorical variables were presented as numbers with percentages (%), and continuous variables were presented as the means and standard deviations. Analysis of variance was used to detect the characteristic differences between the LES groups. A logistic model was fitted to analyse the relationship of the LES groups and every 10-point increase in the LES with the risk of hyperuricemia. To explore whether a nonlinear relationship existed between the LES and the risk of hyperuricemia, the restricted cubic spline (RCS) model was adopted on the basis of five knots (5th, 25th, 50th, 75th, and 95th). We performed stratified analyses by key demographic variables, including age group, sex, living area, educational level, and household income. The significance of the interaction effects was assessed via the p value derived from the product terms between the LES and these stratification factors. The aforementioned analyses were repeated for the HBS and HFS subscales. All analyses were performed via SAS version 9.4, with statistical significance defined as a two-sided p value <0.05.

3 Results

3.1 Basic characteristics

Among the 1,519 participants, 679 (44.70%) were males, and most (62.87%) lived in urban areas (Table 1). The average level of uric acid was 302.78 μmol/L, and the prevalence of hyperuricemia was 13.76%. The high LES, HBS and HFS accounted for 45.04%, 44.85%, and 54.23%, respectively. Those who were younger, lived in urban areas, had a college degree or above and had an annual income of more than 50,000 CNY/year were more likely to have high LES and HFS.

Table 1
www.frontiersin.org

Table 1. Basic characteristics of the participants.

3.2 LES, HBS, HFS and the risk of hyperuricemia

As presented in Table 2, for every 10-unit increase in LES and HFS, the risk of hyperuricemia decreased by 24% (OR = 0.76, 95% CI = 0.66~0.87) and 23% (OR = 0.77, 95% CI = 0.70~0.84), respectively, in the fully adjusted model. Participants with a high LES had a lower risk of hyperuricemia than those with a low LES did (OR = 0.32, 95% CI = 0.14~0.74), and a similar result was found in those with high HFS (OR = 0.29, 95% CI = 0.17~0.49). However, no significant association was found between HBS and the risk of hyperuricemia. Additionally, RCS analysis did not reveal a significant nonlinear relationship between LES, HBS or HFS and the risk of hyperuricemia (Figure 2).

Table 2
www.frontiersin.org

Table 2. The associations between LES, HBS, HFS and the risk of hyperuricemia.

Figure 2
Three line graphs labeled A, B, and C display the odds ratio (OR) with ninety-five percent confidence intervals (CI) as a function of LES, HBS, and HFS, respectively. Graph A shows a decreasing trend for LES, graph B shows a fluctuating trend for HBS, and graph C shows a decreasing trend for HFS. Each graph includes a dashed line at OR equals one, highlighting where the OR equals one, and annotations for p-values for overall and non-linearity.

Figure 2. RCSs of the associations between LES (A), HBS (B), and HFS (C) and the risk of hyperuricemia. LES, life’s essential 8 score; HBS, health behavior score; HFS, health factor score. aBased on 5-knot (5th, 25th, 50th, 75th, 95th), RCS models adjusted for age, sex, living area, ethnicity, educational level, household income, marital status, and eGFR.

3.3 Subgroup analysis of LES, HBS, HFS and the risk of hyperuricemia

Table 3 shows the associations of different groups of LES, HBS, and HFS, with the risk of hyperuricemia. The effect of high LES on the risk of hyperuricemia was stronger among participants aged 45~60 years (OR = 0.13, 95% CI = 0.03~0.56, p for interaction = 0.042), whereas that of high HFS was greater among participants living in urban areas (OR = 0.20, 95% CI = 0.10~0.38, p for interaction = 0.039), those with a college education or above (OR = 0.11, 95% CI = 0.04~0.28, p for interaction = 0.025) and those with an annual income of 20,000~50,000 CNY/year (OR = 0.12, 95% CI = 0.04~0.31, p for interaction = 0.007).

Table 3
www.frontiersin.org

Table 3. Subgroup analyses of the associations between different levels of LES, HBS, HFS and the risk of hyperuricemiaa.

When LES, HBS and HFS were included as continuous variables (Table 4), the associations of every 10-unit increase in both LES and HFS with the risk of hyperuricemia were greater in participants who had an educational level of college or above and an annual household income of 20,000~50,000 CNY/year.

Table 4
www.frontiersin.org

Table 4. Subgroup analysis of the associations between per 10-unit increase in LES, HBS, HFS and the risk of hyperuricemiaa.

4 Discussion

In this study, inverse dose–response associations of the LES and its subscales of HFS with the risk of hyperuricemia in Chinese adults were observed, with 24% and 23% reductions in the risk of hyperuricemia for every 10-unit increase, respectively. Compared with those with low LES and HFS, participants with high LES and HFS were both at lower risk of hyperuricemia. Subgroup analyses revealed that these relationships were stronger among urban, middle-class, and highly educated individuals. In contrast, no significant association was observed with the subscales of the HBS.

Since the release of Life’s Essential 8 in 2022, studies have explored the association between LES and hyperuricemia among U.S. adults; however, research in Chinese populations has been limited to elderly and multiethnic groups. Evidence from U.S. studies demonstrated that participants in the high LES group had a 50%~80% reduction in the risk of hyperuricemia compared with those in the low LES group, and every 10-point increase in LES was associated with a 3%~30% lower risk of hyperuricemia (1518). Among the few studies involving Chinese populations, Jiao et al. (19) reported a significant inverse association between LES and the risk of hyperuricemia in elderly individuals aged 60 years or above, which was supported by multiethnic Chinese data in which ethnic minorities made up half of the participants (20). Additionally, data from the Kailuan Cohort Study in China revealed that an increase in the LES reduced the risk of cardiovascular disease in hyperuricaemic individuals (25). These findings collectively indicated a link between LES and hyperuricemia, yet direct evidence from the general population, predominantly the Han Chinese population, is still lacking. As the associations observed solely in high-risk groups (such as the elderly) or specific groups may overestimate or underestimate the true impact of LES and are often not generalizable, it is thus essential to conduct research in the general population to accurately estimate population attributable risk, ensure the broad applicability of the findings and enable the government to rationally allocate public health resources.

Our findings revealed a significant association between HFS and the risk of hyperuricemia, which was consistent with the findings of previous studies, as each component of HFS has been found to be a risk factor for hyperuricemia (2629). Nevertheless, no association was observed between HBS and the presence of hyperuricemia. In line with our findings, many studies have also shown a stronger effect for HFS, indicating a lack of association or a weak association between HBS and the incidence of hyperuricemia (18, 19). These findings may be due to the inconsistent results of two components of HBS, sleep and smoking. Two Chinese studies have shown that shorter sleep duration was associated with a greater risk of hyperuricemia (30, 31), and U-shaped or negative associations have also been reported (32, 33). For smoking, most studies have focused on gout, the final clinical consequence of hyperuricemia, and have reported complex results (34). For example, data from the Framingham Heart Study revealed that smoking was a protective factor for the incidence of gout (35), which was supported by another Singapore study in men, but no association was observed among women (36). Thus, further research to elucidate the effect of HBS is clearly warranted.

The marker of hyperuricemia, uric acid, is a metabolic product of purine catabolism, and its levels are frequently found to be elevated in individuals with cardiovascular disease (37). This may be because serum uric acid is involved in the pathophysiology of cardiovascular disease through increased oxidative stress, inflammation and apoptosis (38, 39). Another possible reason is that elevated uric acid levels and cardiovascular disease share common risk factors, such as obesity and insulin resistance. More specifically, adipose tissue in obese individuals could increase uric acid production by enhancing the activity of xanthine oxidoreductase and the pentose phosphate pathway (40). Decreased insulin sensitivity might stimulate renal tubules and thus reduce uric acid excretion and increase uric acid reabsorption (41). These findings provided mechanistic support for the relationship between uric acid and cardiovascular disease. Given that LES was established to enhance CVH, finding the inverse association between LES and hyperuricemia is unsurprising.

Strengths of this study include the investigation of the newly updated LES as well as its subscales, the examination of both linear and non-linear relationships, and the contribution to the available evidence on the effectiveness of these metrics in the general Chinese population. Hence, our findings provide insight into the role of LES in evaluating and promoting not only CVH but also hyperuricemia prevention, and may support the wider application of LES in population health policy and practice.

There are also several limitations in our study. First, our study population was drawn solely from Beijing and therefore lacked nationwide representation. Second, as a cross-sectional analysis, this study cannot definitively establish causality, even after adjustment for confounders; therefore, large-scale longitudinal studies are needed to confirm the causal relationships. Third, the use of a food frequency questionnaire in this study was limited by potential recall bias and an inability to accurately assess day-to-day variations in dietary intake. Finally, although we adjusted for multiple confounding factors, we cannot rule out residual confounding due to unmeasured or unknown variables.

In conclusion, our study demonstrated a negative association between the LES and the risk of hyperuricemia among general Chinese population in Beijing, as well as its subscale of HFS. These findings highlight the potential of LES as a public health strategy for alleviating the disease burden of hyperuricemia. Future longitudinal cohort studies are warranted to establish a causal relationship between LES and the risk of hyperuricemia and to elucidate interactions among LES components.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

This study involving humans was approved by Ethical Committee of the Chinese Center for Disease Control and Prevention (No: 201614). This study was conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

RD: Writing – original draft, Writing – review & editing. JD: Data curation, Project administration, Writing – review & editing. BY: Investigation, Writing – review & editing. YZ: Investigation, Writing – review & editing. YY: Investigation, Writing – review & editing. RM: Investigation, Writing – review & editing. YS: Conceptualization, Data curation, Formal analysis, Methodology, Project administration, Writing – review & editing.

Funding

The author(s) declared that financial support was not received for this work and/or its publication.

Acknowledgments

We would like to thank all the subjects and staff for their cooperation and work.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that Generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

CVH, cardiovascular health; CNHS, Chinese Nutrition and Health Surveillance; ASCVD, atherosclerosis; CKD, chronic kidney disease; LES, Life’s Essential 8 score; BMI, body mass index; Non-HDL-C, non-high-density lipoprotein cholesterol; DASH, Dietary Approaches to Stop Hypertension; HBS, health behavior score; HFS, health factor score; eGFR, estimated glomerular filtration rate; CNY, Chinese Yuan; RCS, restricted cubic spline.

References

1. Joosten, LAB, Crişan TOBjornstad, P, and Johnson, RJ. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol. (2020) 16:75–86. doi: 10.1038/s41584-019-0334-3,

PubMed Abstract | Crossref Full Text | Google Scholar

2. Chen-Xu, M, Yokose, C, Rai, SK, Pillinger, MH, and Choi, HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the National Health and nutrition examination survey, 2007-2016. Arthritis Rheumatol. (2019) 71:991–9. doi: 10.1002/art.40807,

PubMed Abstract | Crossref Full Text | Google Scholar

3. Zhang, M, Zhu, X, Wu, J, Huang, Z, Zhao, Z, Zhang, X, et al. Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015–16 and 2018–19. Front Immunol. (2021) 12:791983. doi: 10.3389/fimmu.2021.791983,

PubMed Abstract | Crossref Full Text | Google Scholar

4. Lin, KC, Lin, HY, and Chou, P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol. (2000) 27:1501–5.

Google Scholar

5. Biradar, MI, Chiang, KM, Yang, HC, Huang, YT, and Pan, WH. The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components. Int J Obes. (2020) 44:865–74. doi: 10.1038/s41366-019-0487-9,

PubMed Abstract | Crossref Full Text | Google Scholar

6. De Becker, B, Borghi, C, Burnier, M, and van de Borne, P. Uric acid and hypertension: a focused review and practical recommendations. J Hypertens. (2019) 37:878–83. doi: 10.1097/hjh.0000000000001980,

PubMed Abstract | Crossref Full Text | Google Scholar

7. Ma, L, Wang, J, Ma, L, and Wang, XM. The link between hyperuricemia and diabetes: insights from a quantitative analysis of scientific literature. Front Endocrinol (Lausanne). (2024) 15:1441503. doi: 10.3389/fendo.2024.1441503,

PubMed Abstract | Crossref Full Text | Google Scholar

8. Borghi, C, Agabiti-Rosei, E, Johnson, RJ, Kielstein, JT, Lurbe, E, Mancia, G, et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med. (2020) 80:1–11. doi: 10.1016/j.ejim.2020.07.006,

PubMed Abstract | Crossref Full Text | Google Scholar

9. Zhang, T, Gu, Y, Meng, G, Zhang, Q, Liu, L, Wu, H, et al. Genetic risk, adherence to a healthy lifestyle, and hyperuricemia: the TCLSIH cohort study. Am J Med. (2023) 136:476–83.e5. doi: 10.1016/j.amjmed.2023.01.004,

PubMed Abstract | Crossref Full Text | Google Scholar

10. Singh, JA, Reddy, SG, and Kundukulam, J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. (2011) 23:192–202. doi: 10.1097/BOR.0b013e3283438e13,

PubMed Abstract | Crossref Full Text | Google Scholar

11. Li, M, Hou, W, Zhang, X, Hu, L, and Tang, Z. Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies. Atherosclerosis. (2014) 232:265–70. doi: 10.1016/j.atherosclerosis.2013.11.051,

PubMed Abstract | Crossref Full Text | Google Scholar

12. Grayson, PC, Kim, SY, LaValley, M, and Choi, HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). (2011) 63:102–10. doi: 10.1002/acr.20344,

PubMed Abstract | Crossref Full Text | Google Scholar

13. Lloyd-Jones, DM, Hong, Y, Labarthe, D, Mozaffarian, D, Appel, LJ, Van Horn, L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation. (2010) 121:586–613. doi: 10.1161/circulationaha.109.192703

Crossref Full Text | Google Scholar

14. Lloyd-Jones, DM, Allen, NB, Anderson, CAM, Black, T, Brewer, LC, Foraker, RE, et al. Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. (2022) 146:e18–43. doi: 10.1161/cir.0000000000001078,

PubMed Abstract | Crossref Full Text | Google Scholar

15. Wang, M, and Meng, H. Association between cardiovascular health assessed by life's essential 8 and hyperuricemia in U.S. adults: the NHANES 2009–2020. Front Endocrinol (Lausanne). (2024) 15:1445787. doi: 10.3389/fendo.2024.1445787,

PubMed Abstract | Crossref Full Text | Google Scholar

16. Wang, X, and Fan, J. Association between life's essential 8 and hyperuricemia among adults in the United States: insights from NHANES 2005–2018. Front Med (Lausanne). (2024) 11:1455164. doi: 10.3389/fmed.2024.1455164,

PubMed Abstract | Crossref Full Text | Google Scholar

17. Liu, P, Kadier, K, Cui, C, Peng, X, Hou, W, Ainiwaer, A, et al. Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health. J Health Popul Nutr. (2024) 43:167. doi: 10.1186/s41043-024-00665-6,

PubMed Abstract | Crossref Full Text | Google Scholar

18. Han, Y, Di, H, Wang, Y, Yi, J, Cao, Y, Han, X, et al. Exploration of the association between new “life’s essential 8” with hyperuricemia and gout among US adults. Qual Life Res. (2024) 33:3351–62. doi: 10.1007/s11136-024-03777-y,

PubMed Abstract | Crossref Full Text | Google Scholar

19. Jiao, Y, Wang, L, Hong, X, Li, W, Jiang, H, Jia, X, et al. Association between life's essential 8 and hyperuricemia in the Chinese elderly. Asia Pac J Clin Nutr. (2025) 34:677–88. doi: 10.6133/apjcn.202508_34(4).0018,

PubMed Abstract | Crossref Full Text | Google Scholar

20. Wang, Y, Meng, Q, Zhang, X, Baima, K, Chen, L, Dai, Y, et al. Life's essential 8, life's simple 7 and the odds of hyperuricaemia: results from the China multi-ethnic cohort study. Rheumatol Adv Pract. (2024) 8:rkae009. doi: 10.1093/rap/rkae009,

PubMed Abstract | Crossref Full Text | Google Scholar

21. Yu, D, Zhao, L, Zhang, J, Yang, Z, Yang, L, Huang, J, et al. China nutrition and health surveys (1982-2017). China CDC Wkly. (2021) 3:193–5. doi: 10.46234/ccdcw2021.058,

PubMed Abstract | Crossref Full Text | Google Scholar

22. Goyal, P, Balkan, L, Ringel, JB, Hummel, SL, Sterling, MR, Kim, S, et al. The Dietary Approaches To Stop Hypertension (DASH) diet pattern and incident heart failure. J Card Fail. (2021) 27:512–21. doi: 10.1016/j.cardfail.2021.01.011,

PubMed Abstract | Crossref Full Text | Google Scholar

23. Lei, Y, Zhang, L, Shan, Z, Gan, Q, Xie, Q, Huang, Y, et al. Poor healthy lifestyle and life's essential 8 are associated with higher risk of new-onset migraine: a prospective cohort study. J Headache Pain. (2024) 25:82. doi: 10.1186/s10194-024-01785-4,

PubMed Abstract | Crossref Full Text | Google Scholar

24. Gong, W, Hu, X, Cui, H, Zhao, Y, Lin, H, Sun, P, et al. Socioeconomic status and lifestyle as factors of multimorbidity among older adults in China: results from the China health and retirement longitudinal survey. Front Public Health. (2025) 13:1586091. doi: 10.3389/fpubh.2025.1586091,

PubMed Abstract | Crossref Full Text | Google Scholar

25. Xu, Y, Gao, J, Zhang, J, Liu, S, Yang, P, Wang, Y, et al. Life’s essential 8 and cardiovascular disease among patients with hyperuricemia: the Kailuan cohort study. Curr Probl Cardiol. (2024) 49:102862. doi: 10.1016/j.cpcardiol.2024.102862,

PubMed Abstract | Crossref Full Text | Google Scholar

26. Liu, Z, Wei, Y, Wang, J, and Ying, H. Analysis of the dose–response relationship between body mass index and hyperuricemia in residents of Haidian District Beijing in 2019. Chin J Health Stat. (2023) 40:259–63.

Google Scholar

27. Krishnan, E, Pandya, BJ, Chung, L, Hariri, A, and Dabbous, O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. (2012) 176:108–16. doi: 10.1093/aje/kws002,

PubMed Abstract | Crossref Full Text | Google Scholar

28. Peng, TC, Wang, CC, Kao, TW, Chan, JY, Yang, YH, Chang, YW, et al. Relationship between hyperuricemia and lipid profiles in US adults. Biomed Res Int. (2015) 2015:127596. doi: 10.1155/2015/127596,

PubMed Abstract | Crossref Full Text | Google Scholar

29. Borghi, C, Agnoletti, D, Cicero, AFG, Lurbe, E, and Virdis, A. Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk. Hypertension. (2022) 79:1927–36. doi: 10.1161/hypertensionaha.122.17956

Crossref Full Text | Google Scholar

30. Yu, H, Shi, K, Yang, H, Sun, D, Lv, J, Ma, Y, et al. Association of Sleep Duration with hyperuricemia in Chinese adults: a prospective longitudinal study. Int J Environ Res Public Health. (2022) 19:8105. doi: 10.3390/ijerph19138105,

PubMed Abstract | Crossref Full Text | Google Scholar

31. An, Y, Li, X, Ouyang, F, and Xiao, S. Association between nocturnal sleep duration and the risk of hyperuricemia among Chinese government employees: a cross-sectional study. Front Public Health. (2022) 10:1055778. doi: 10.3389/fpubh.2022.1055778,

PubMed Abstract | Crossref Full Text | Google Scholar

32. Lee, YC, Son, DH, and Kwon, YJ. U-shaped association between sleep duration, C-reactive protein, and uric acid in Korean women. Int J Environ Res Public Health. (2020) 17:2657. doi: 10.3390/ijerph17082657,

PubMed Abstract | Crossref Full Text | Google Scholar

33. Zhou, C, Gu, M, Yin, L, Yin, W, Liu, J, Zhu, Y, et al. Low serum uric acid levels may be a potential biomarker of poor sleep quality in patients with Parkinson's disease. Sleep Med. (2023) 105:9–13. doi: 10.1016/j.sleep.2023.03.011,

PubMed Abstract | Crossref Full Text | Google Scholar

34. Jee, Y, Jeon, C, Sull, JW, Go, E, and Cho, SK. Association between smoking and gout: a meta-analysis. Clin Rheumatol. (2018) 37:1895–902. doi: 10.1007/s10067-018-4118-y,

PubMed Abstract | Crossref Full Text | Google Scholar

35. Wang, W, and Krishnan, E. Cigarette smoking is associated with a reduction in the risk of incident gout: results from the Framingham heart study original cohort. Rheumatology (Oxford). (2015) 54:91–5. doi: 10.1093/rheumatology/keu304,

PubMed Abstract | Crossref Full Text | Google Scholar

36. Gee Teng, G, Pan, A, Yuan, JM, and Koh, WP. Cigarette smoking and the risk of incident gout in a prospective cohort study. Arthritis Care Res (Hoboken). (2016) 68:1135–42. doi: 10.1002/acr.22821,

PubMed Abstract | Crossref Full Text | Google Scholar

37. Chen, X, Cheng, S, Huang, L, Chen, X, Jin, N, Hong, J, et al. Serum uric acid, body mass index, and cardiovascular diseases: a multiple two-step mendelian randomization study. Nutr Metab Cardiovasc Dis. (2024) 34:2386–94. doi: 10.1016/j.numecd.2024.05.023

Crossref Full Text | Google Scholar

38. Copur, S, Demiray, A, and Kanbay, M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur J Intern Med. (2022) 103:4–12. doi: 10.1016/j.ejim.2022.04.022,

PubMed Abstract | Crossref Full Text | Google Scholar

39. Prabhakar, AP, and Lopez-Candales, A. Uric acid and cardiovascular diseases: a reappraisal. Postgrad Med. (2024) 136:615–23. doi: 10.1080/00325481.2024.2377952,

PubMed Abstract | Crossref Full Text | Google Scholar

40. Mutailipu, K, Guo, J, Yin, J, Wang, Y, Lu, L, Jia, X, et al. Association between TyG-BMI index and hyperuricemia in adult women. Endocrinol Diabetes Metab. (2025) 8:e70028. doi: 10.1002/edm2.70028,

PubMed Abstract | Crossref Full Text | Google Scholar

41. Wan, X, Xu, C, Lin, Y, Lu, C, Li, D, Sang, J, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. (2016) 64:925–32. doi: 10.1016/j.jhep.2015.11.022,

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: adults, cardiovascular health, Chinese Nutrition and Health Surveillance, hyperuricemia, Life’s Essential 8

Citation: Deng R, Duan J, Yu B, Zhang Y, Yao Y, Ma R and Sha Y (2026) Adherence to Life’s Essential 8 is associated with lower risk of hyperuricemia among adults in Beijing, China. Front. Nutr. 12:1738146. doi: 10.3389/fnut.2025.1738146

Received: 03 November 2025; Revised: 26 December 2025; Accepted: 29 December 2025;
Published: 12 January 2026.

Edited by:

María Rubín García, University of León, Spain

Reviewed by:

Yong Zhang, Chongqing Medical University, China
Zibo Gao, Guangzhou University of Chinese Medicine, China

Copyright © 2026 Deng, Duan, Yu, Zhang, Yao, Ma and Sha. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yimei Sha, c2hheWltZWlAYmpjZGMub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.